Back

Long-term outcomes of patients with tachycardia-induced cardiomyopathy

27 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Aspects of epidemiology, aetiology, and outcomes in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Teodor Serban

University Hospital Basel, Basel (Switzerland)

6 More presentations in this session

Presentation thumbnail
Symptoms vs. pathology and outcomes in patients with reduced ejection fraction
Doctor E. Kanonidis (Alexandroupolis, GR)
Abstract Slides Video
Presentation thumbnail
Predictive utility of health-related quality of life and the 6-minute walking test in transthyretin amyloid cardiomyopathy - a comparison
Mr M. Poledniczek (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Usefulness of Neutrophil-to-Lymphocyte Ratio (NLR) in predicting adverse outcomes in adult patients with heart failure : A systematic review and meta analysis
Miss A. Bhanushali (Rochester, US)
Abstract Slides
Presentation thumbnail
HFrEF phenotyping in real life
Doctor A. Weidenhammer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Role of renal function in patients with advanced heart failure: insights from the help-hf registry
Doctor A. Villaschi (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Aspects of epidemiology, aetiology, and outcomes in heart failure

The Event

Event poster

ESC Congress 2023

27 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term prognosis of tachycardia-induced cardiomyopathy: survival outcomes and hospitalization trends in acute heart failure patients
thumbnail
Congress Presentation
Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction
thumbnail
Congress Presentation
Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources